http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2080307-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9af917dd1e6e93fa16bca5901dcc6f2f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-191
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 1991-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_589c692c844161c398322b4ceffdd81f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a719f36ed0d6490007339788a7d74627
publicationDate 1996-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2080307-T3
titleOfInvention PHARMACEUTICAL COMPOSITIONS.
abstract THE INVENTION PROVIDES PRODUCTS CONTAINING THE TUMOR NECROSIS (TNF) FACTOR AND TAUROLIDINE AND / OR TAURULTAM AS A COMBINED PREPARATION FOR SIMULTANEOUS USE BOTH SEPARATED AND SEQUENTIAL IN PATIENTS SUFFERING FROM MEDICAL CONDITIONS TREATED WITH TNF.
priorityDate 1990-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29566
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514376
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749226

Total number of triples: 23.